Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. EPA approves use of Lysol Disinfectant Spray against COVID-19

Published 07/07/2020, 02:28
Updated 07/07/2020, 02:35
© Reuters. A MTA staff uses a Lysol to clean a station at the lobby of Grand Central Station following the outbreak of coronavirus disease (COVID-19) in New York City

(Reuters) - UK-based Reckitt Benckiser Group Plc (L:RB) said on Tuesday that the U.S. Environmental Protection Agency (EPA) has approved use of its Lysol Disinfectant Spray against COVID-19.

The U.S. EPA said in a statement that the agency had approved two products, Lysol Disinfectant Spray and Lysol Disinfectant Max Cover Mist, based on laboratory testing that showed the products were effective against COVID-19.

Reckitt Benckiser reported record sales growth in the first quarter and predicted a stronger-than-expected performance in 2020 as customers stocked up on Lysol disinfectants, Mucinex cough syrup and Dettol soap ahead of the coronavirus lockdowns.

"Lysol is currently testing the efficacy of other disinfectant products in the brand portfolio," Ferran Rousaud, marketing director for Lysol, said in a statement.

Lysol's parent company has warned people against using disinfectants to treat the new coronavirus, after U.S. President Donald Trump suggested researchers try putting disinfectants into patients' veins.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.